SGC-CBP30 – 5 mg

Brand:
Cayman
CAS:
1613695-14-9
Storage:
-20
UN-No:
Non-Hazardous - /

cAMP-responsive element-binding protein binding protein (CREBBP) and E1A-associated protein p300 (EP300) are transcriptional co-activators. Each contains a bromodomain, which recognizes acetylated lysine residues on target proteins. SGC-CBP30 is a potent inhibitor of CREBBP and EP300 bromodomains (IC50s = 21-69 and 38 nM, respectively).{26201} Developed by the Structural Genomics Consortium (SGC), this compound displays over 40-fold selectivity for CREBBP over BRD4(1) and is functional in cells.  

 

SKU: - Category:

Description

A potent inhibitor of CREBBP and EP300 bromodomains (IC50s = 21-69 and 38 nM, respectively)


Formal name: 2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-1H-benzimidazole

Synonyms: 

Molecular weight: 509

CAS: 1613695-14-9

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Chromatin Reader Interactions||Research Area|Epigenetics, Transcription, & Translation|Readers|Bromodomains